Suvretta Capital Management 13F holdings, Q3 2022
Holdings as of September 30, 2022 · filings on SEC EDGAR · latest filing →
Suvretta Capital Management disclosed 72 US equity positions worth $2.4bn in its Q3 2022 13F filing. The largest position was UNH at 5.1% of the reported book, followed by UNP and LVS. Against the Q2 2022 filing, it opened 8 new positions, added to 17 and reduced 19 among the top 50 holdings.
What did Suvretta Capital Management own in Q3 2022? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2022 |
|---|---|---|---|---|---|---|---|
| 1 | UNH UNITEDHEALTH GROUP INC | Healthcare | 5.1% | $121.7m | 240,997 | 0% | held |
| 2 | UNP UNION PAC CORP | Industrials | 4.4% | $103.9m | 533,105 | 0% | held |
| 3 | LVS LAS VEGAS SANDS CORP | Consumer Cyclical | 3.8% | $89.8m | 2,393,951 | -18% | reduced |
| 4 | MSFT MICROSOFT CORP | Technology | 3.8% | $89.1m | 382,380 | 53% | added |
| 5 | DIS DISNEY WALT CO | Communication Services | 3.7% | $87.4m | 926,850 | 164% | added |
| 6 | AMZN AMAZON COM INC | Consumer Cyclical | 3.5% | $82.9m | 733,460 | – | new |
| 7 | OTIS OTIS WORLDWIDE CORP | Industrials | 3.5% | $82.8m | 1,297,480 | 0% | held |
| 8 | EL LAUDER ESTEE COS INC | Consumer Defensive | 3.4% | $79.8m | 369,583 | 26% | added |
| 9 | RPRX ROYALTY PHARMA PLC | Healthcare | 3.1% | $74.0m | 1,842,718 | -40% | reduced |
| 10 | GPN GLOBAL PMTS INC | Industrials | 3.0% | $71.2m | 658,992 | 129% | added |
| 11 | META META PLATFORMS INC | Communication Services | 2.8% | $67.6m | 498,290 | – | new |
| 12 | HLT HILTON WORLDWIDE HLDGS INC | Consumer Cyclical | 2.8% | $65.8m | 545,171 | 51% | added |
| 13 | IQV IQVIA HLDGS INC | Healthcare | 2.7% | $64.8m | 357,685 | -9% | reduced |
| 14 | TPR TAPESTRY INC | Consumer Cyclical | 2.6% | $62.0m | 2,180,922 | -3% | reduced |
| 15 | TTWO TAKE-TWO INTERACTIVE SOFTWAR | Communication Services | 2.5% | $58.4m | 536,170 | – | new |
| 16 | DHR DANAHER CORPORATION | Healthcare | 2.5% | $58.4m | 226,142 | 4% | added |
| 17 | NOW SERVICENOW INC | Technology | 2.5% | $58.2m | 154,150 | 504% | added |
| 18 | TMO THERMO FISHER SCIENTIFIC INC | Healthcare | 2.5% | $58.2m | 114,725 | -5% | reduced |
| 19 | KURA KURA ONCOLOGY INC | Healthcare | 2.3% | $55.5m | 4,063,128 | 1% | added |
| 20 | CANADIAN PAC RY LTD | 2.2% | $51.8m | 776,276 | 22% | added | |
| 21 | MA MASTERCARD INCORPORATED | Financial Services | 2.2% | $51.7m | 181,691 | -13% | reduced |
| 22 | TMUS T-MOBILE US INC | Communication Services | 2.1% | $49.6m | 369,828 | 372% | added |
| 23 | V VISA INC | Financial Services | 2.0% | $48.3m | 271,968 | -16% | reduced |
| 24 | COR AMERISOURCEBERGEN CORP | Healthcare | 1.9% | $46.3m | 341,779 | 9% | added |
| 25 | HORIZON THERAPEUTICS PUB L | 1.9% | $44.1m | 712,561 | 46% | added | |
| 26 | ARCELLX INC | 1.8% | $42.2m | 2,249,533 | -9% | reduced | |
| 27 | INTRA-CELLULAR THERAPIES INC | 1.7% | $39.6m | 851,958 | -36% | reduced | |
| 28 | XYZ BLOCK INC | Technology | 1.5% | $36.4m | 661,540 | -3% | reduced |
| 29 | MCK MCKESSON CORP | Healthcare | 1.5% | $35.6m | 104,850 | 0% | held |
| 30 | PROK PROKIDNEY CORP | 1.2% | $28.8m | 3,193,175 | – | new | |
| 31 | FULC FULCRUM THERAPEUTICS INC | Healthcare | 1.2% | $28.5m | 3,528,000 | 5% | added |
| 32 | KEZAR LIFE SCIENCES INC | 1.2% | $28.2m | 3,275,520 | -26% | reduced | |
| 33 | STRO SUTRO BIOPHARMA INC | Healthcare | 1.2% | $27.9m | 5,020,000 | 8% | added |
| 34 | COGT COGENT BIOSCIENCES INC | Healthcare | 1.2% | $27.8m | 1,862,600 | 210% | added |
| 35 | 290A CHINOOK THERAPEUTICS INC | 1.2% | $27.3m | 1,390,000 | -22% | reduced | |
| 36 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 1.1% | $27.1m | 959,214 | -59% | reduced |
| 37 | INSM INSMED INC | Healthcare | 1.1% | $26.5m | 1,230,800 | -41% | reduced |
| 38 | EYPT EYEPOINT PHARMACEUTICALS INC | Healthcare | 1.1% | $25.6m | 3,233,597 | 9% | added |
| 39 | 4XC1 KALVISTA PHARMACEUTICALS INC | 1.0% | $24.8m | 1,707,100 | -11% | reduced | |
| 40 | MARINUS PHARMACEUTICALS INC | 1.0% | $23.5m | 3,537,700 | 1% | added | |
| 41 | PROTHENA CORP PLC | 0.8% | $19.2m | 316,531 | – | new | |
| 42 | GFL GFL ENVIRONMENTAL INC | Industrials | 0.8% | $19.1m | 753,818 | -17% | reduced |
| 43 | MAR MARRIOTT INTL INC NEW | Consumer Cyclical | 0.8% | $18.9m | 134,800 | -54% | reduced |
| 44 | POINT BIOPHARMA GLOBAL INC | 0.8% | $18.0m | 2,330,902 | -23% | reduced | |
| 45 | HRTX HERON THERAPEUTICS INC | Healthcare | 0.5% | $11.8m | 2,807,000 | -14% | reduced |
| 46 | LLY LILLY ELI & CO | Healthcare | 0.5% | $11.4m | 35,200 | – | new |
| 47 | LEGN LEGEND BIOTECH CORP | Healthcare | 0.5% | $11.2m | 274,200 | – | new |
| 48 | PEPG PEPGEN INC | Healthcare | 0.5% | $10.7m | 1,180,984 | -0% | held |
| 49 | AKILI INC | 0.3% | $8.2m | 3,624,163 | – | new | |
| 50 | ALVOTECH | 0.3% | $6.8m | 1,000,000 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.